INE ACQUISITION SUB, LLC – Trademark Portfolio
Entity Type: 16
INE ACQUISITION SUB, LLC holds 19 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 18 filings in this category. The portfolio also extends into Class 3 (Cosmetics & Cleaning) across 3 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include KONA GOLD. The owner is based in IRVING, TX.
8312 STERLING ST
IRVING, TX 75063
Showing of trademarks Trademarks
Trademark Classifications
INE ACQUISITION SUB, LLC's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Meat, fish, poultry and game; meat extracts; preserved, frozen, dried and cooked fruits
Frequently Asked Questions
How many trademarks does INE ACQUISITION SUB, LLC have?
INE ACQUISITION SUB, LLC has 19 U.S. trademarks filed with the USPTO. Of these, 1 registered, 2 abandoned, 16 cancelled.
What trademark classes does INE ACQUISITION SUB, LLC file in?
INE ACQUISITION SUB, LLC files trademarks across 3 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 3 (Cosmetics & Cleaning), Class 29 (Meats & Processed Foods). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are INE ACQUISITION SUB, LLC's most well-known trademarks?
INE ACQUISITION SUB, LLC's registered trademark portfolio includes well-known marks such as KONA GOLD. These are among 1 currently registered trademark in the portfolio.
What is INE ACQUISITION SUB, LLC's trademark registration success rate?
INE ACQUISITION SUB, LLC has a 5% trademark registration rate, with 1 out of 19 resolved applications resulting in successful registration. Currently, 0 applications are pending review.